Baudouin Standaert

GlaxoSmithKline

Health Economics Director

5 Moore Drive

RTP, NC 27709

United States

Learn more about SSRN Profiles

SCHOLARLY PAPERS

3

DOWNLOADS

0

TOTAL CITATIONS

0

Feedback

Scholarly Papers (3)

Sort by:

Actions:

View:
Selected
Original List
All Versions Hide All Versions
All Abstracts Hide All Abstracts

(Rank)

1.

Use of Modelling Techniques to Estimate the Number of Additional Events Avoided Through Early Versus Delayed Intervention: The Case of Rotavirus Vaccination

iHEA 2007 6th World Congress: Explorations in Health Economics Paper

Posted: 13 Jun 2007

Baudouin Standaert

GlaxoSmithKline

Abstract:

2.

Assessing the Risk of Cervical Cancer Development when Introducing New Prophylactic Management Schemes at Country Level Using a Markov Model: The Case Applied to France

iHEA 2007 6th World Congress: Explorations in Health Economics Paper

Posted: 13 Jun 2007

Bruno Detournay, Abdelkader El-Hasnaoui, Nadia Demarteau and Baudouin Standaert

Cemka-Eval, GlaxoSmithKline France, IMS-Health Belgium and GlaxoSmithKline

Abstract:

3.

Predicting the Impact of a Cervical Cancer Vaccine on Cancer Incidence and Mortality in Canada: A Modeled Cancer Registry Based Analysis

iHEA 2007 6th World Congress: Explorations in Health Economics Paper

Posted: 10 Jun 2007

Andrea Marie Anonychuk, Minh Do, Maraki Fikre Merid, Ba' Pham, Georges Van Kriekinge and Baudouin Standaert

GlaxoSmithKline Canada, GlaxoSmithKline Canada, University of Toronto - Department of Health Policy and Management, GlaxoSmithKline - Canada, GlaxoSmithKline Biologicals and GlaxoSmithKline

Abstract:

Feedback

All content on this site: Copyright © 2026 Elsevier Inc., its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.

We use cookies to help provide and enhance our service and tailor content.

To learn more, visit .